1. Medicines and Healthcare products Regulatory Agency (MHRA) (2022). The British Pharmacopeia, 2022. Monographs: Tianeptine Sodium.
2. Malen, C., Danree, B., en Laye, S.G., and Poignant, J.-C. (1973). Tricyclic Compounds. (#3758528), U.S. Patent, Available online: https://patentimages.storage.googleapis.com/94/81/93/24ca0b63a45d8a/US3758528.pdf.
3. Rangisetty, J.B., Pallagurla, M.R., and Bhudeti, R. (2010). Novel Process for the Preparation of 7-((3-Chloro-6-methyI-5,5-dioxo-6,11-dihydro dibenzo(c,f) (1,2) thiazepin-11-yl)amino) heptanoate. (WO 2010/070667A2), International Patent.
4. Cell atrophy and loss in depression: Reversal by antidepressant treatment;Banasr;Curr. Opin. Cell Biol.,2011
5. Tianeptine: A review of its use in depressive disorders;Wagstaff;CNS Drugs,2001